(Total Views: 385)
Posted On: 04/02/2020 11:16:58 AM
Post# of 30067
Quite a few catalysts on deck for 1H 2020.
- Date from 2nd half of Lympro LymPro Amyloid PET correlation study.
- Todos Uplist to Nasdaq
- Complete acquisition of Provista
- Tech transfer TBIA & LymPro tech into US CLIA lab.
From their Feb 2020 Corporate Presentation
Looks like the acquisition will follow the uplist.
Details will follow later.
Of course there are far more time sensitive developments that are going on right now that includes Todos' use of Provista CLIA lab.
Things are moving rapidly and lots of moving parts.
Updates to come.
Aloha
- Date from 2nd half of Lympro LymPro Amyloid PET correlation study.
- Todos Uplist to Nasdaq
- Complete acquisition of Provista
- Tech transfer TBIA & LymPro tech into US CLIA lab.
From their Feb 2020 Corporate Presentation
Looks like the acquisition will follow the uplist.
Details will follow later.
Of course there are far more time sensitive developments that are going on right now that includes Todos' use of Provista CLIA lab.
Things are moving rapidly and lots of moving parts.
Updates to come.
Aloha
(1)
(0)
